Literature DB >> 23172105

Crimean-Congo hemorrhagic fever nosocomial infection in a immunosuppressed patient, Pakistan: case report and virological investigation.

Zahra Hasan1, Faisal Mahmood, Bushra Jamil, Barry Atkinson, Murtaza Mohammed, Azra Samreen, Lamia Altaf, Tariq Moatter, Roger Hewson.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is endemic in the Baluchistan province, Pakistan. Sporadic outbreaks of CCHF occur throughout the year especially in individuals in contact with infected livestock. Nosocomial transmission remains a risk due to difficulties in the diagnosis of CCHF and limited availability of facilities for the isolation of suspected patients. Rapid diagnosis of CCHF virus infection is required for early management of the disease and to prevent transmission. This study describes the case of a 43-year-old surgeon who contracted CCHF during a surgical procedure in Quetta, Baluchistan and who was transferred to a tertiary care facility at the Aga Khan University Hospital, Karachi within 1 week of contracting the infection. Diagnosis of CCHF was made using a rapid real-time reverse transcription polymerase chain reaction (RT-PCR) assay for CCHF viral RNA. The patient had chronic hepatitis B and hepatitis D infection for which he had previously received a liver transplant. He proceeded to develop classic hemorrhagic manifestations and succumbed to the infection 14 days post-onset of disease. There was no further nosocomial transmission of the CCHF during the hospital treatment of the surgeon. Early diagnosis of CCHF enables rapid engagement of appropriate isolation, barrier nursing and infection control measures thus preventing nosocomial transmission of the virus.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23172105     DOI: 10.1002/jmv.23473

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Sequence Optimized Real-Time Reverse Transcription Polymerase Chain Reaction Assay for Detection of Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Jeffrey W Koehler; Korey L Delp; Adrienne T Hall; Scott P Olschner; Brian J Kearney; Aura R Garrison; Louis A Altamura; Cynthia A Rossi; Timothy D Minogue
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

2.  Sero-Epidemiological Survey of Crimean-Congo Hemorrhagic Fever among the Human Population of the Punjab Province in Pakistan.

Authors:  Muhammad Furqan Shahid; Muhammad Zubair Shabbir; Kamran Ashraf; Muzaffar Ali; Saima Yaqub; Aziz Ul-Rahman; Nageen Sardar; Nadia Mukhtar; Zarfishan Tahir; Tahir Yaqub
Journal:  Virol Sin       Date:  2020-02-26       Impact factor: 4.327

3.  Second International Conference on Crimean-Congo Hemorrhagic Fever.

Authors:  Jessica R Spengler; Dennis A Bente; Mike Bray; Felicity Burt; Roger Hewson; Gülay Korukluoglu; Ali Mirazimi; Friedemann Weber; Anna Papa
Journal:  Antiviral Res       Date:  2017-12-02       Impact factor: 5.970

Review 4.  Crimean-Congo hemorrhagic fever and expansion from endemic regions.

Authors:  Jessica R Spengler; Éric Bergeron; Christina F Spiropoulou
Journal:  Curr Opin Virol       Date:  2019-01-16       Impact factor: 7.090

5.  Nosocomial infection of CCHF among health care workers in Rajasthan, India.

Authors:  Pragya D Yadav; Deepak Y Patil; Anita M Shete; Prasad Kokate; Pulkit Goyal; Santosh Jadhav; Sanjeev Sinha; Divya Zawar; Surendra K Sharma; Arti Kapil; D K Sharma; Kamlesh J Upadhyay; Devendra T Mourya
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

Review 6.  Development of vaccines against Crimean-Congo haemorrhagic fever virus.

Authors:  Stuart D Dowall; Miles W Carroll; Roger Hewson
Journal:  Vaccine       Date:  2017-07-04       Impact factor: 3.641

Review 7.  The reasons why Pakistan might be at high risk of Crimean Congo haemorrhagic fever epidemic; a scoping review of the literature.

Authors:  Muhammad Atif; Anum Saqib; Raazeyah Ikram; Muhammad Rehan Sarwar; Shane Scahill
Journal:  Virol J       Date:  2017-03-23       Impact factor: 4.099

Review 8.  Ribavirin for treating Crimean Congo haemorrhagic fever.

Authors:  Samuel Johnson; Nicholas Henschke; Nicola Maayan; Inga Mills; Brian S Buckley; Artemisia Kakourou; Rachel Marshall
Journal:  Cochrane Database Syst Rev       Date:  2018-06-05

9.  Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.

Authors:  Önder Ergönül; Şiran Keske; Melis Gökçe Çeldir; İlayda Arjen Kara; Natalia Pshenichnaya; Gulzhan Abuova; Lucille Blumberg; Mehmet Gönen
Journal:  Emerg Infect Dis       Date:  2018-09       Impact factor: 6.883

10.  Genome Sequence of Ex-Afghanistan Crimean-Congo Hemorrhagic Fever Virus SCT Strain, from an Imported United Kingdom Case in October 2012.

Authors:  John Chamberlain; Barry Atkinson; Christopher H Logue; Jennie Latham; Edmund N C Newman; Roger Hewson
Journal:  Genome Announc       Date:  2013-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.